Concepts (54)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenal Cortex Neoplasms | 3 | 2013 | 5 | 0.530 |
Why?
|
| Adrenocortical Carcinoma | 2 | 2013 | 4 | 0.430 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 86 | 0.300 |
Why?
|
| Securin | 1 | 2013 | 1 | 0.120 |
Why?
|
| Adrenocortical Adenoma | 1 | 2012 | 2 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2012 | 88 | 0.100 |
Why?
|
| Paclitaxel | 1 | 2012 | 140 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 236 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 498 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2008 | 16 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2008 | 11 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 18 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2008 | 20 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 14 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2008 | 47 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 188 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2008 | 173 | 0.070 |
Why?
|
| Prognosis | 2 | 2013 | 2093 | 0.070 |
Why?
|
| Cholesterol | 1 | 2008 | 331 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2008 | 714 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 565 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 1851 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 37 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 84 | 0.030 |
Why?
|
| Male | 3 | 2013 | 37321 | 0.030 |
Why?
|
| Mitotane | 1 | 2012 | 1 | 0.030 |
Why?
|
| Albumin-Bound Paclitaxel | 1 | 2012 | 3 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 231 | 0.030 |
Why?
|
| Albumins | 1 | 2012 | 72 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 160 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 132 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 99 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 770 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 304 | 0.020 |
Why?
|
| Humans | 4 | 2013 | 68618 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 508 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2012 | 254 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1745 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 81 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 114 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2008 | 92 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 160 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1070 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 517 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 14862 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 21147 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 5717 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 8474 | 0.010 |
Why?
|
| Female | 2 | 2013 | 38074 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 2223 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 5731 | 0.010 |
Why?
|
| Brain | 1 | 2008 | 2176 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 21403 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 20881 | 0.010 |
Why?
|